[TRVI] YoY Quarter Result on 31-Mar-2023 [#Q1]

Stock
[TRVI] Trevi Therapeutics, Inc.
Announcement Date
11-May-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -16.30%
YoY- 12.66%
Quarter Report
TRVI's Result
TRVI's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -10,910 -6,408 -7,334 -8,386 -8,482 -4,806 -4,076 17.81%
Tax -8 -7 -5 -15 -9 -4 -25 -17.28%
NP -10,902 -6,401 -7,329 -8,371 -8,473 -4,802 -4,051 17.92%
Tax Rate - - - - - - - -
Total Cost 10,902 6,401 7,329 8,371 8,473 4,802 4,051 17.92%
Ratio Analysis
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/03/23 31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 CAGR
EPS -0.11 -0.06 -0.24 -0.43 -0.48 -0.27 -0.45 -20.90%
EPS Diluted -0.11 -0.06 -0.24 -0.43 -0.48 -0.27 -0.45 -20.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.